GLAXO’s IMITREX FOR MIGRAINE WILL BE AVAILABLE IN MARCH AFTER DEC. 28 APPROVAL; FIRM WILL CONDUCT PHASE IV STUDY IN PREGNANT WOMEN IN LIEU OF REGISTRY

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".